Cargando…

PDAC, the Influencer Cancer: Cross-Talk with Tumor Microenvironment and Connected Potential Therapy Strategies

SIMPLE SUMMARY: The aim of this review was to gather a deeper insight on the mechanisms of Pancreatic Ductal Adenocarcinoma (PDAC), with a particular focus on its biomolecular variety and underlying intracellular and intercellular mechanisms. This was obtained through a critical approach to the curr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mercanti, Leonardo, Sindaco, Maria, Mazzone, Mariangela, Di Marcantonio, Maria Carmela, Piscione, Mariagrazia, Muraro, Raffaella, Mincione, Gabriella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251917/ https://www.ncbi.nlm.nih.gov/pubmed/37296886 http://dx.doi.org/10.3390/cancers15112923

Ejemplares similares

Eradication of Helicobacter pylori and Gastric Cancer: A Controversial Relationship
por: Piscione, Mariagrazia, et al.
Publicado: (2021)

A Narrative Review on Non-Cirrohotic Portal Hypertension: Not All Portal Hypertensions Mean Cirrhosis
por: Fiordaliso, Michele, et al.
Publicado: (2023)

Doxorubicin-induced oxidative and nitrosative stress: Mitochondrial connexin 43 is at the crossroads
por: Pecoraro, Michela, et al.
Publicado: (2020)

Effects of H(2)O(2) Treatment Combined With PI3K Inhibitor and MEK Inhibitor in AGS Cells: Oxidative Stress Outcomes in a Model of Gastric Cancer
por: Savino, Luca, et al.
Publicado: (2022)

Open Questions in Cold Atmospheric Plasma Treatment in Head and Neck Cancer: A Systematic Review
por: Perrotti, Vittoria, et al.
Publicado: (2022)

Emerging Role of Oxidative Stress on EGFR and OGG1-BER Cross-Regulation: Implications in Thyroid Physiopathology
por: Moscatello, Carmelo, et al.
Publicado: (2022)

Identification of the zinc finger 216 (ZNF216) in human carcinoma cells: a potential regulator of EGFR activity
por: Mincione, Gabriella, et al.
Publicado: (2016)

Modulation of Type I Interferon Responses to Influence Tumor-Immune Cross Talk in PDAC
por: Cattolico, Carlotta, et al.
Publicado: (2022)

Helicobacter pylori ATCC 43629/NCTC 11639 Outer Membrane Vesicles (OMVs) from Biofilm and Planktonic Phase Associated with Extracellular DNA (eDNA)
por: Grande, Rossella, et al.
Publicado: (2015)

Culprits of PDAC resistance to gemcitabine and immune checkpoint inhibitor: Tumour microenvironment components
por: Hsu, Sheng-Kai, et al.
Publicado: (2022)

EGF and TGF-β1 Effects on Thyroid Function
por: Mincione, Gabriella, et al.
Publicado: (2011)

Detection and Physicochemical Characterization of Membrane Vesicles (MVs) of Lactobacillus reuteri DSM 17938
por: Grande, Rossella, et al.
Publicado: (2017)

Fendiline Enhances the Cytotoxic Effects of Therapeutic Agents on PDAC Cells by Inhibiting Tumor-Promoting Signaling Events: A Potential Strategy to Combat PDAC
por: Alhothali, Marwa, et al.
Publicado: (2019)

The immunomodulatory role of IDO1-Kynurenine-NAD(+) pathway in switching cold tumor microenvironment in PDAC
por: Anu, R. I., et al.
Publicado: (2023)

Scaling the immune incline in PDAC
por: Rojas, Luis A., et al.
Publicado: (2021)

Mitochondrial Metabolism in PDAC: From Better Knowledge to New Targeting Strategies
por: Reyes-Castellanos, Gabriela, et al.
Publicado: (2020)

The Antibiofilm Effect of a Medical Device Containing TIAB on Microorganisms Associated with Surgical Site Infection
por: Puca, Valentina, et al.
Publicado: (2019)

Antimicrobial and Antibiofilm Activities of New Synthesized Silver Ultra-NanoClusters (SUNCs) Against Helicobacter pylori
por: Grande, Rossella, et al.
Publicado: (2020)

ENO1 expression and Erk phosphorylation in PDAC and their effects on tumor cell apoptosis in a hypoxic microenvironment
por: Sun, Huizhi, et al.
Publicado: (2022)

Transverse Space Charge Effect During Bunch Compression in PDAC1 and PDAC2 Compressor Ring
por: Franchetti, Giuliano
Publicado: (2000)

The role of survivin in the progression of pancreatic ductal adenocarcinoma (PDAC) and a novel survivin-targeted therapeutic for PDAC
por: Brown, Matthew, et al.
Publicado: (2020)

Autophagy is required for PDAC glutamine metabolism
por: Seo, Ju-Won, et al.
Publicado: (2016)

SIRT 1 Overexpression is Associated with Metastasis of Pancreatic Ductal Adenocarcinoma (PDAC) and Promotes Migration and Growth of PDAC Cells
por: Li, Siqin, et al.
Publicado: (2016)

Synthesis and Evaluation of Thymol-Based Synthetic Derivatives as Dual-Action Inhibitors against Different Strains of H. pylori and AGS Cell Line
por: Sisto, Francesca, et al.
Publicado: (2021)

Exosomes in the Treatment of Pancreatic Cancer: A Moonshot to PDAC Treatment?
por: Papadakos, Stavros P., et al.
Publicado: (2022)

Synthesis and Biological Evaluation of Carvacrol-Based Derivatives as Dual Inhibitors of H. pylori Strains and AGS Cell Proliferation
por: Sisto, Francesca, et al.
Publicado: (2020)

Overexpression of Mesothelin in Pancreatic Ductal Adenocarcinoma (PDAC)
por: Le, Kai, et al.
Publicado: (2020)

The Microbiome in PDAC—Vantage Point for Future Therapies?
por: Pfisterer, Nina, et al.
Publicado: (2022)

Cancer Associated Fibroblast (CAF) Regulation of PDAC Parenchymal (CPC) and CSC Phenotypes Is Modulated by ECM Composition
por: Cannone, Stefania, et al.
Publicado: (2022)

Tumor Suppressor Role of Wild-Type P53-Dependent Secretome and Its Proteomic Identification in PDAC
por: Butera, Giovanna, et al.
Publicado: (2022)

Detection and Quantification of eDNA-Associated Bacterial Membrane Vesicles by Flow Cytometry
por: Puca, Valentina, et al.
Publicado: (2019)

Circulating miRNAs as Noninvasive Biomarkers for PDAC Diagnosis and Prognosis in Mexico
por: Álvarez-Hilario, Lissuly Guadalupe, et al.
Publicado: (2023)

Combatting PDAC with two tumor-targeting small RNAs
por: Kasinski, Andrea L.
Publicado: (2019)

Biological Hallmarks and New Therapeutic Approaches for the Treatment of PDAC
por: Digiacomo, Graziana, et al.
Publicado: (2021)

Cell Lineage Infidelity in PDAC Progression and Therapy Resistance
por: Malinova, Antonia, et al.
Publicado: (2021)

Loss of FGFR4 promotes the malignant phenotype of PDAC
por: D’Agosto, Sabrina, et al.
Publicado: (2022)

Targeting KRAS in PDAC: A New Way to Cure It?
por: He, Qianyu, et al.
Publicado: (2022)

Modifiable Pancreatic Ductal Adenocarcinoma (PDAC) Risk Factors
por: Michalak, Natalia, et al.
Publicado: (2023)

Cytoplasmic TRAIL-R1 is a positive prognostic marker in PDAC
por: Gundlach, Jan-Paul, et al.
Publicado: (2018)

Upregulated MicroRNA-483-3p is an Early Event in Pancreatic Ductal Adenocarcinoma (PDAC) and as a Powerful Liquid Biopsy Biomarker in PDAC
por: Shao, Huilin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_aodhjgnpntm8lmuscsp5oj5h3l